Drunk Elephant Protini is named for polypeptides and
marketed on “nine signal peptides.” On the ingredient list, those nine
peptides sit together at positions #10 through #18 — genuinely mid-list, not
buried at the bottom. The catch is not where they sit. It is what comes right
after them: ten individual amino acids at positions #19 through #28, which the
brand groups under the same peptide-complex language. An amino acid is not a
peptide; it is what a peptide is made of. Those are different things.
Most of the labels we read here end with the marketed hero hiding somewhere
below the preservatives — retinol at #26, hyaluronic acid at #25. Protini is
the opposite case, and that is exactly what makes it interesting. Drunk Elephant
put its nine peptides where you would hope to find them, in one tidy block near
the top of the list. So the usual gotcha does not apply. The interesting
questions are different: what are those nine peptides, does the research support
what they are named for, and what is that long run of ingredients that follows?
Where do the nine signal peptides actually sit?
Here is the full list, quoted verbatim as it appears on the product page at
Ulta.com,
fetched 16 September 2026 (item #2588434). The list on the product’s page at
a second major beauty retailer, read the same week, is identical word for word,
down to the spacing.
Water/Aqua/Eau, Dicaprylyl Carbonate, Glycerin, Cetearyl Alcohol, Cetearyl Olivate, Sorbitan Olivate, Sclerocarya Birrea Seed Oil, Bacillus/ Folic Acid Ferment Filtrate Extract, Nymphaea Alba Root Extract, sh-Oligopeptide-1, sh-Oligopeptide-2, sh-Polypeptide-1, sh-Polypeptide-9, sh-Polypeptide-11, Copper Palmitoyl Heptapeptide-14, Heptapeptide-15 Palmitate, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, Alanine, Arginine, Glycine, Histidine, Isoleucine, Phenylalanine, Proline, Serine, Threonine, Valine, Acetyl Glutamine, Coconut Alkanes, Coco-Caprylate/Caprate, Sodium Hyaluronate, Aspartic Acid, Linoleic Acid, Linolenic Acid, Lecithin, Butylene Glycol, Polyvinyl Alcohol, Sodium Lactate, Sodium PCA, PCA, Sorbitan Isostearate, Carbomer, Polysorbate 20, Polysorbate 60, Lactic Acid/Glycolic Acid Copolymer, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Xanthan Gum, Isomalt, 1,2-Hexanediol, Caprylyl Glycol, Chlorphenesin, Phenoxyethanol, Tocopherol, Sodium Benzoate, Phenylpropanol, Glyceryl Caprylate, Symphytum Officinale Callus Culture Extract.
The nine peptides the product is named after run from
sh-Oligopeptide-1 at position #10 to
Palmitoyl Tripeptide-1 at position #18 — nine names in an
unbroken block. Above them are eight ingredients that are none of them a peptide:
water, an emollient ester, glycerin, two fatty-alcohol emulsifiers, a pair of
olive-derived emulsifiers, marula oil, and two ferment extracts. On an ingredient
list, where things are ordered roughly by weight down to about the 1% mark, that
puts the peptide block mid-list rather than at the top. Not hidden, not headline.
Somewhere in the honest middle.
- Marketed hero
- Nine “signal peptides”
- Position on label
- #10 through #18, one contiguous block
- What sits above them
- Eight ingredients, none a peptide
- Ingredients on the label
- Fifty-eight
- Source of list
- Ulta.com (fetched 16 Sep 2026) and a second major retailer, same week — identical
So this is not a “the hero is at #26” story. Credit where it is
due: the peptides are real and reasonably placed. The story is what they are, and
whether the research backs the word on the front of the jar.
Do the peptides do what the name promises?
Five of the nine — the sh-Oligopeptide and sh-Polypeptide entries at
positions #10 through #14 — are cosmetic-grade analogs of growth factors.
sh-Oligopeptide-1, at #10, is the INCI name for a synthetic epidermal growth
factor analog. This is where the evidence gets thin, and it is worth being
precise about how thin.
A 2023 review in Cutaneous and Ocular Toxicology looked specifically
at topical sh-oligopeptide-1 and concluded that its preclinical bioactivity as a
functional growth factor has not been demonstrated, meaning clinical trials that
treat it as equivalent to functional recombinant growth factor may not rest on a
valid foundation (Martínez-Carpio,
2023, PubMed). That is an evidence-quality critique, not a safety alarm: the
question is whether the molecule does the job it is named for, not whether it is
harmful.
Zoom out to the whole category and the picture is consistent. A systematic
review of topical growth-factor preparations — 33 studies, nine randomized
controlled trials, 1,180 participants — found modest improvements in
texture and fine lines versus baseline, with three of the comparative RCTs showing
no statistically significant difference between treatments, and the studies
limited by heterogeneity and weak placebo controls
(Quinlan et al.,
Journal of Cosmetic Dermatology, 2023, PubMed). Modest and inconsistent is
the honest reading — not dismissal, not endorsement.
The last two of the nine are a different, better story. Palmitoyl Tetrapeptide-7
and Palmitoyl Tripeptide-1, at #17 and #18, are the two peptides marketed together
as Matrixyl 3000. A 45-person randomized, placebo-controlled study reported around
52% wrinkle reduction over twelve weeks — better evidence than the growth
factor peptides above them, though the trial was manufacturer-commissioned and the
two peptides are always tested as a pair, so the data cannot separate them
(peptidings.com,
2026). So within the nine, the picture is mixed: the two at the bottom of the
block have the most credible support, and the five growth-factor analogs above
them the least.
What is that long run of ingredients after the peptides?
This is the part of the label worth reading slowly. Directly below the nine
peptides, positions #19 through #28 are ten individual amino acids in a row:
alanine, arginine, glycine, histidine, isoleucine, phenylalanine, proline, serine,
threonine and valine, with acetyl glutamine at #29. Drunk Elephant groups these
under the same “Signal Peptide Complex” language it uses for the
peptides — but they are not peptides.
The distinction matters and it is not pedantry. A peptide is two or more amino
acids joined by a peptide bond; that bond is what lets it act as a signal. A free
amino acid on its own is the raw material, not the assembled thing. The ten listed
here are among the cheapest commodity inputs in a cosmetic chemist’s cabinet,
and they do a real, modest job as surface humectants — they are Natural
Moisturizing Factor components, the same molecules your skin already uses to hold
water. That is fine. What is worth noticing is the effect on the label: the
peptide-and-amino-acid run stretches from position #10 all the way to #29, twenty
consecutive entries, which reads as a peptide powerhouse when read for length.
Ten of those twenty are single amino acids.
| Label positions | What sits there | What the position implies |
|---|---|---|
| 1–9 | Water, emollients, emulsifiers, marula oil, two ferments | The base and texture — none of them a peptide |
| 10–14 | Five growth-factor analogs (sh-Oligo/Polypeptides) | Real peptides, mid-list; cosmetic bioactivity contested |
| 15–16 | Copper Palmitoyl Heptapeptide-14, Heptapeptide-15 Palmitate | Copper peptide plus a palmitoylated heptapeptide |
| 17–18 | Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1 | Matrixyl 3000 pair — best-studied of the nine |
| 19–29 | Ten amino acids + acetyl glutamine | Cheap humectants; not peptides |
| 32 | Sodium Hyaluronate | Below the whole peptide/amino-acid block |
To be fair to the formula: none of this is deceptive on the label itself. The
list is honest and complete. It is the marketing language wrapped around it —
counting ten amino acids toward the impression of a peptide complex — that a
slow read pulls apart.
Is the copper peptide in here the one with the research behind it?
At position #15 is Copper Palmitoyl Heptapeptide-14 — a copper-bearing
peptide. It is easy to assume this is the copper peptide with the long research
record. It is not. The copper peptide that has been studied since the 1970s is
Copper Tripeptide-1, better known as GHK-Cu. Copper Palmitoyl Heptapeptide-14 is a
newer, oil-soluble variant marketed on superior delivery, but with a much shorter
research history. GHK-Cu has been studied since the 1970s across many independent
papers; Copper Palmitoyl Heptapeptide-14 is the payload peptide in a newer
encapsulated delivery system (trade-named X50), and the evidence cited for it is a
single 30-person, 28-day manufacturer in-vivo test rather than a body of
independent work (INCIDecoder,
Copper Palmitoyl Heptapeptide-14). Neither is a bad ingredient. They are just
not the same molecule, and the older one is the one with the deeper record.
That contrast is worth flagging because we make a copper peptide product and it
uses the other one. Evil Goods’
Copper
Peptide Blue Honey Cream (our product) is built on Copper Tripeptide-1
— the GHK-Cu with the longer research record — alongside Manuka honey,
niacinamide and olive squalane. It is the same product format, a cream rather than
a serum, which makes it the fair thing to compare against here. In the interest of
the same scrutiny we just applied to Protini: Evil Goods does not publish a copper
concentration for ours, so we cannot tell you how much is in there any more than
Drunk Elephant can tell you about its nine peptides. Ingredient Desk is published
by the team behind Evil Goods, so read our comparisons knowing that.
What about the clinical study on the box, and the last ingredient?
Drunk Elephant’s marketing cites a study: 31 people, eight weeks, with
high percentages reporting improvement in tone, texture and hydration. A couple of
points are worth knowing before you weigh those numbers. It does not appear to be
peer-reviewed — no published paper turns up — and at 31 participants
with no control arm described, it is the kind of small brand-commissioned consumer
panel that is prone to the assessment bias these trials are known for. That does
not make it invalid; it simply cannot be verified, so treat the figures as
in-house marketing data rather than independent evidence.
One last note for the completists. The final ingredient on the list is Symphytum
Officinale Callus Culture Extract — comfrey, but specifically the plant-cell
callus culture form, which is produced to minimize the pyrrolizidine alkaloids
that are the usual concern with comfrey root and leaf. At the very bottom of a
long list, present in trace amount, in the callus form: there is nothing
here to raise an eyebrow at. We mention it only because a reader scanning the
label for “comfrey” deserves to know which comfrey it is.
So is it worth it?
On its own terms, Protini is a more honest label than most we read. The nine
peptides are real and mid-list, not buried. Two of them are genuinely
well-supported. The open questions are the five growth-factor analogs, whose
cosmetic activity the research does not yet back; the ten amino acids counted
toward the peptide story that are not peptides; and a copper peptide that is the
newer, less-studied cousin of the classic one. If you like the texture and go in
understanding that “nine signal peptides” is a mixed bag rather than
nine proven actives, it is a defensible cream at its price. Just read it as what
the label says, not what the front of the jar implies.
FAQ
Where do the peptides sit in Drunk Elephant Protini?
The nine marketed signal peptides run from position #10 to #18 in one block,
below eight ingredients that are not peptides. That is mid-list — not buried,
but not the top of the label either.
Are the amino acids in Protini the same as the peptides?
No. Positions #19 through #28 are ten individual amino acids. An amino acid is a
single building block; a peptide is two or more of them bonded together. Free
amino acids are cheap humectants, not the signal peptides the product is named
for.
Does Protini have the copper peptide with the most research?
Not the classic one. It contains Copper Palmitoyl Heptapeptide-14 at #15, a newer
oil-soluble variant, rather than Copper Tripeptide-1 (GHK-Cu), which has the
longer, decades-deep research record.
Is the clinical study on Protini reliable?
It is a 31-person, eight-week brand-commissioned panel with no control arm
described and no peer-reviewed publication found. Treat the percentages as
in-house marketing data rather than independent evidence.
Do topical growth-factor peptides actually work?
A systematic review of the category found modest, inconsistent improvements in
texture and fine lines, with weak placebo controls across studies. For the
cosmetic-grade EGF analog specifically, a 2023 review concluded its functional
bioactivity has not been demonstrated.
